A stepped wedge cluster randomized control trial of dried blood spot testing to improve the uptake of hepatitis C antibody testing within UK prisons

European Journal of Public Health

Volumn 25, Issue 2, 2015, Pages 351-357

  Craine, Noel ^a   Whitaker, Rhiannon ^b   Perrett, Stephanie ^a   Zou, Lu ^b   Hickman, Matthew ^c   Lyons, Marion ^a  

^a PUBLIC HEALTH WALES   (United Kingdom)

^b BANGOR UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY;

BLOOD; CLUSTER ANALYSIS; CONTROLLED STUDY; DRIED BLOOD SPOT TESTING; FEMALE; HEPATITIS C; HUMAN; MALE; PRISONER; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; STATISTICS AND NUMERICAL DATA; UNITED KINGDOM;

CLUSTER ANALYSIS; DRIED BLOOD SPOT TESTING; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; PRISONERS; REPRODUCIBILITY OF RESULTS; UNITED KINGDOM;

EID: 84926610416     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/cku096     Document Type: Article

References (40)

1. Murray E, Jones D. Audit into blood-borne virus services in Her Majesty's Prison Service. Int J STD AIDS 2008;19:347-8.
2. Champion JK, Taylor A, Hutchinson S, et al. Incidence of hepatitis C virus Infection and associated risk factors among Scottish prison inmates: a cohort study. Am J Epidemiol 2004;159:514-9.
3. Bird GA, Gore SM, Cameron S, et al. Anonymous HIV surveillance with risk factor elicitation at Scotland's largest prison, Barlinnie. Aids 1995;9:801-8.
4. Seaman SR, Gore SM, Brettle RP. Injecting drug users in Edinburgh have a high rate of recidivism. Addiction 2000;95:791-2.
5. Taylor A, Munro A, Allen E, et al. Low incidence of hepatitis C virus among prisoners in Scotland. Addiction 2013;108:1296-304.
6. Weild AR, Gill ON, Bennett D, et al. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. Commun Dis Public Health 2000;3:121-6.
7. Gore SM, Bird AG, Cameron SO, et al. Prevalence of hepatitis C in prisons: WASH-C surveillance linked to self-reported risk behaviours. QJM 1999;92:25-32.
8. Horne JA. Screening for hepatitis C virus in the Dartmoor prison population: an observational study. J Public Health 2004;26:372-5.
9. Hutchinson SJ, Goldberg DJ, Gore SM, et al. Hepatitis B outbreak at Glenochil prison during January to June 1993. Epidemiol Infect 1998;121:185-91.
10. Goldberg D, Taylor A, McGregor J, et al. A lasting public health response to an outbreak of HIV infection in a Scottish prison? Int J STD AIDS 1998;9:25-30.
11. Viswanathan U, Beaumont A, O'Moore E, et al. Hepatitis B transmission event in an English prison and the importance of immunization. J Public Health 2011;33: 193-6.
12. Kirwan P, Evans B, Brant L. Sentinel Surveillance of Hepatitis Testing Study Group. Hepatitis C and B testing in English prisons is low but increasing. J Public Health 2011;33:197-204.
13. Department of Health. Prison Health Performance and Quality Indicators, 2012. Available at: https://www.gov.uk/government/publications/prison-healthperformance-and-quality-indicator-report-and-guidance (14 May 2013, date last accessed).
14. Health Protection Agency. National Survey of Hepatitis C Services in Prisons in England. London: HPA, 2012, Available at: http://www.hpa.org.uk/webc/ HPAwebFile/HPAweb-C/1317135271616 (14 May 2013, date last accessed).
15. Skipper C, Guy JM, Parkes J, et al. Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy. Gut 2003;52:1500-4.
16. Khaw FM, Stobbart L, Murtagh MJ. 'I just keep thinking I haven't got it because I'm not yellow': a qualitative study of the factors that influence the uptake of Hepatitis C testing by prisoners. BMC Public Health 2007;7:98.
17. National Institute for Health and Clinical Excellence. Boceprevir for the Treatment of Genotype Chronic Hepatitis C. TA253. London: NICE, 2012. Available at: http://guidance.nice.org.uk/TA253 (14 May 2013, date last accessed).
18. National Institute for Health and Clinical Excellence. Telaprevir for the Treatment of Genotype Chronic Hepatitis C. TA252. London: NICE, 2012. Available at: http://guidance.nice.org.uk/TA252 (14 May 2013, date last accessed).
19. Sutton AJ, Edmunds WJ, Gill ON. Estimating the cost-effectiveness of detecting cases of chronic hepatitis C infection on reception into prison. BMC Public Health 2006;6:170.
20. Sutton AJ, Edmunds WJ, Sweeting MJ, et al. The cost-effectiveness of screening and treatment for hepatitis C in prisons in England and Wales: a cost utility analysis. J Viral Hepat 2008;15:797-808.
21. National Institute for Health and Clinical Excellence. Hepatitis B and C: Ways to Promote and Offer Testing to People at Increased Risk of Infection. PH43. London: NICE, 2012. Available at: http://www.nice.org.uk/PH43 (14 May 2013, date last accessed).
22. Judd A, Parry J, Hickman M, et al. Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots. J Med Virol 2003;71:49-55.
23. Craine N, Parry J, O'Toole J, et al. Improving blood-borne viral diagnosis; clinical audit of the uptake of dried blood spot testing offered by a substance misuse service. J Viral Hepat 2009;16:219-22.
24. Hickman M, McDonald T, Judd A, et al. Increasing the uptake of hepatitis C virus testing among injecting drug users in specialist drug treatment and prison settings by using dried blood spots for diagnostic testing: a cluster randomized controlled trial. J Viral Hepat 2008;15:250-4.
25. Welsh Assembly Government. Blood Borne Viral Hepatitis Action Plan for Wales 2010-2015. Cardiff: WAG, 2010, Available at: http://wales.gov.uk/docs/phhs/ publications/100226actionplanen.pdf (14 May 2013, date last accessed).
26. Public Health Wales, HM Prison Service, G4S. A Delivery Plan for the Provision of Seamless Liver Health Care in Welsh Prisons. To support the delivery of the Welsh Government's Blood Borne Viral hepatitis Action Plan for Wales 2010-2015. Cardiff: Public Health Wales, 2012, Available at: http://howis.wales.nhs.uk/sites3/ Documents/457/Liver%20Health%20Care%20in%20Welsh%20Prisons%20A4% 20pdf.pdf (16 May 2013, date last accessed).
27. Hussey MA, Hughes JP. Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials 2007;28:182-91.
28. Cleveland WS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 1979;74:829-36.
29. Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
30. McCullagh P. Generalized linear models. Eur J Oper Res 2006;16:285-92.
31. Van Buuren S, Groothuis-Oudshoorn K. mice: Multivariate imputation by chained equations in R. J Stat Softw 2011;45:1-67.
32. van Buuren S. Flexible Imputation of Missing Data. Boca Raton: CRC Press, 2012.
33. Oakley A, Strange V, Bonell C, et al. Process evaluation in randomised controlled trials of complex interventions. BMJ 2006;332:413-6.
34. Craig P, Dieppe P, Macintyre S, et al. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008;337:a1655.
35. Sheard L, Wright NM, El-Sayeh HG, et al. The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) prisons project: a randomised controlled trial comparing dihydrocodeine and buprenorphine for opiate detoxification. Subst Abuse Treat Prev Policy 2009;4:1.
36. Shearer J, Wodak A.N, Dolan K.A. Evaluation of a prison-based naltrexone program. Int J Prison Health 2007;3:214-24.
37. Lobmaier P.P, Kunoe N, Waal H. Treatment research in prison: Problems and solutions in a randomized trial. Addict Res Theory 2010;18:1-13.
38. Kavasery R, Maru DS, Cornman-Homonoff J, et al. Routine opt-out HIV testing strategies in a female jail setting: a prospective controlled trial. PLoS One 2009;4:e7648.
39. Kavasery R, Maru DS, Sylla LN, et al. A prospective controlled trial of routine opt-out HIV testing in a men's jail. PLoS One 2009;4:e8056.
40. Martin N K, Hickman M, Miners A, et al. Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons. BMJ Open 2013;3:e003153.